Searched for
HEMANTH RAO
Badminton: Saneeth Dayanand enters Australian Open's men's singles main drawSaneeth Dayanand has qualified for the men's singles main draw at the Australian Open badminton tournament. He won his qualifying matches o...- PV Sindhu eyes title breakthrough, Ayush Shetty leads men's single charge at Australian Open 2026Two-time Olympic-medallist PV Sindhu aims to end her title drought at the Australian Open. Rising star Ayush Shetty spearheads the men's si...
- Vijay Hazare Trophy 2026: Schedule, live streaming, teams, standings and matches featuring Virat Kohli and Rohit SharmaThe Vijay Hazare Trophy 2025-26 commences on December 24, featuring 32 teams and top Indian cricketers like Virat Kohli and Rohit Sharma. T...
- Intern sings Kannada song at Marathi-Hindi karaoke night. What followed next was a sweet Leonardo DiCaprio moment for herIn Nashik, a young intern's hesitant karaoke performance of the Kannada song 'Sapta Saagaradaache Ello' unexpectedly became the night's hig...
- Heady growth of desi brands: The rise of India's single-malt industryThe climate in India allows whiskey to mature faster, but international standards require a three-year maturity period. Indian makers argue...
- Actor Rakshit Shetty announces OTT release of 777 Charlie. Check out when and where to watchActor Rakshit Shetty's latest flick 777 Charlie is a heartwarming tale of a friendship between a man and a dog. The movie's lead actor has ...
- Indian mythologies written at large scale can put 'Game of Thrones' to shame, says actor Rana DaggubatiThe 37-year-old actor is producing several show currently.
- APFT to set up flight training academy at Kalaburagi airportAPFT offers courses such as Commercial Pilot License Multi Engine, Instrument Rating (CPL-ME/IR) among others, the release added.
- Sell Divi's Laboratories, target Rs 475.0 : Manas JaiswalSell Divi's Laboratories Ltd. at a price target of Rs 475.0 and a stop loss at Rs 606.0 from entry point
- Buy Divi's Laboratories, target Rs 678: Siddharth BhamreBuy Divi's Laboratories Ltd. at a price target of Rs 678.0 and a stop loss at Rs 609.0 from entry point
- Buy Divi's Laboratories Ltd. target Rs 660.0 : Sarvendra SrivastavaBuy Divi's Laboratories Ltd. at a price target of Rs 660.0 and a stoploss at Rs 618.4 from entry point
- How fast should startups expand? The jury is outCurrently present in Pune, Mumbai and Bengaluru, ecommerce platform for automobile parts and services SparesHub, plans to expand to four mo...
- Actor-director Rakshit Shetty feels the challenge ahead is to keep the audience occupiedKannada cinema in the 80s & 90s saw youth flicks that had catchy music, cocky one-liners & dream sequences promising an entertaining thorou...
- Meet the revolutionaries of Kannada cinema who are challenging the traditionalThe industry responded with protectionist instincts, by enforcing an informal ban on dubbing any visual content and allowing it to be isola...
- Medical programmes: Which is better, a Common entrance test or multiple exams?Govt is thinking of challenging scrapping of a common National Eligibility & Entrance Test for medical programmes, but students are in two ...
- Fee of top 10 rank holders in CET to be reimbursed: RV DeshpandeThe college fees of the top tank rank holders in this year's CET, will be reimbursed by the Karnataka Examination Authority (KEA), Minister...
- RIL taking 40% stake in Rewas PortReliance Industries (RIL) will pay around Rs 200 crore to pick up close to 40% stake in Rewas Port (RPL).
Load More
